Abstract:Regulatory T (Treg) cells are required to control immune responses and maintain homeostasis, but are a significant barrier to antitumour immunity<a href="/articles/s41586-020-2246-4#ref-CR1">1</a>. Conversely, Treg instability, characterized by loss of the master transcription factor Foxp3 and acquisition of proinflammatory properties<a href="/articles/s41586-020-2246-4#ref-CR2">2</a>, can promote autoimmunity and/or facilitate more effective tumour immunity<a href="/articles/s41586-020-2246-4#ref-CR3">3</a>,<a href="/articles/s41586-020-2246-4#ref-CR4">4</a>. A comprehensive understanding of the pathways that regulate Foxp3 could lead to more effective Treg therapies for autoimmune disease and cancer. The availability of new functional genetic tools has enabled the possibility of systematic dissection of the gene regulatory programs that modulate Foxp3 expression. Here we developed a CRISPR-based pooled screening platform for phenotypes in primary mouse Treg cells and applied this technology to perform a targeted loss-of-function screen of around 500 nuclear factors to identify gene regulatory programs that promote or disrupt Foxp3 expression. We identified several modulators of Foxp3 expression, including ubiquitin-specific peptidase 22 (Usp22) and ring finger protein 20 (Rnf20). Usp22, a member of the deubiquitination module of the SAGA chromatin-modifying complex, was revealed to be a positive regulator that stabilized Foxp3 expression; whereas the screen suggested that Rnf20, an E3 ubiquitin ligase, can serve as a negative regulator of Foxp3. Treg-specific ablation of Usp22 in mice reduced Foxp3 protein levels and caused defects in their suppressive function that led to spontaneous autoimmunity but protected against tumour growth in multiple cancer models. Foxp3 destabilization in Usp22-deficient Treg cells could be rescued by ablation of Rnf20, revealing a reciprocal ubiquitin switch in Treg cells. These results reveal previously unknown modulators of Foxp3 and demonstrate a screening method that can be broadly applied to discover new targets for Treg immunotherapies for cancer and autoimmune disease.

Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function

Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function

Neuropilin-1 Identifies a New Subpopulation of TGF--Induced Foxp3<SUP>+</SUP> Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation

Lineage Tracking the Generation of T Regulatory Cells From Microbial Activated T Effector Cells in Naive Mice

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

An NF-κB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function.

Tcf1 and Lef1 Are Required for the Immunosuppressive Function of Regulatory T Cells

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

Noc4L-Mediated Ribosome Biogenesis Controls Activation of Regulatory and Conventional T Cells.

Ndfip1 Restricts Mtorc1 Signalling And Glycolysis In Regulatory T Cells To Prevent Autoinflammatory Disease

CD1d-independent NK1.1+ Treg cells are IL2-inducible Foxp3+ T cells co-expressing immunosuppressive and cytotoxic molecules

Nutrient Mtorc1 Signaling Underpins Regulatory T Cell Control of Immune Tolerance

FOXP3 exon 2 controls T reg stability and autoimmunity

Functional reprogramming of regulatory T cells in the absence of Foxp3

NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1

Transcriptional control of central T cell tolerance by NR4A family nuclear receptors

Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion

Immune Homeostasis Enforced by Co-Localized Effector and Regulatory T Cells

Inflammation Negatively Regulates FOXP3 and Regulatory T-cell Function Via DBC1.

CRISPR screen in regulatory T cells reveals modulators of Foxp3